MedChemBio – collective research (Q11151): Difference between revisions
Jump to navigation
Jump to search
(Removed claim: summary (P836): 1.The subscheme will help in the production phase of advanced therapy products (LPMT). The aim is to ensure the quality of the results of the pre-validation and validation studies and to develop the quality control methods for new products to complete the development and start of the production of the LPMT in GSP. This will include the launch of a study to identify the bio-markers of the efficacy of the LPMT., remove_old_english_translation) |
(Created claim: summary (P836): 1. subproject will help in the stage of production of evaluated drugs. products for modern therapy (LPMT). The aim is to ensure quality results of pre-validation and valid. studies, and to develop specific methods of quality control of new products to complete development and start production of LPMT in the SVP mode. It will also include the launch of a study aimed at identifying the biomarkers of the efficacy of LPMT. a., translated_summary) |
||||||||||||||
| Property / summary | |||||||||||||||
1. subproject will help in the stage of production of evaluated drugs. products for modern therapy (LPMT). The aim is to ensure quality results of pre-validation and valid. studies, and to develop specific methods of quality control of new products to complete development and start production of LPMT in the SVP mode. It will also include the launch of a study aimed at identifying the biomarkers of the efficacy of LPMT. a. (English) | |||||||||||||||
| Property / summary: 1. subproject will help in the stage of production of evaluated drugs. products for modern therapy (LPMT). The aim is to ensure quality results of pre-validation and valid. studies, and to develop specific methods of quality control of new products to complete development and start production of LPMT in the SVP mode. It will also include the launch of a study aimed at identifying the biomarkers of the efficacy of LPMT. a. (English) / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / summary: 1. subproject will help in the stage of production of evaluated drugs. products for modern therapy (LPMT). The aim is to ensure quality results of pre-validation and valid. studies, and to develop specific methods of quality control of new products to complete development and start production of LPMT in the SVP mode. It will also include the launch of a study aimed at identifying the biomarkers of the efficacy of LPMT. a. (English) / qualifier | |||||||||||||||
point in time: 22 October 2020
| |||||||||||||||
Revision as of 15:40, 22 October 2020
Project in Czech Republic financed by DG Regio
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | MedChemBio – collective research |
Project in Czech Republic financed by DG Regio |
Statements
9,107,700.0 Czech koruna
0 references
13,011,000.0 Czech koruna
0 references
70 percent
0 references
19 January 2017
0 references
31 August 2019
0 references
MedChemBio
0 references
49°35'41.89"N, 17°16'31.12"E
0 references
77900
0 references
1.podprojekt pomůže ve fázi výroby hodnocených léčiv. přípravků pro moderní terapie(LPMT). Cílem je zajistit kvalitní výsledky pre-validačních a valid. studií, a vyvinout specif. metody kontroly kvality nových produktů pro dokončení vývoje a zahájení výroby LPMT v režimu SVP. Součástí bude i zahájení studie směřující k identifikaci biomarkerů účinnosti LPMT. a. (Czech)
0 references
1. subproject will help in the stage of production of evaluated drugs. products for modern therapy (LPMT). The aim is to ensure quality results of pre-validation and valid. studies, and to develop specific methods of quality control of new products to complete development and start production of LPMT in the SVP mode. It will also include the launch of a study aimed at identifying the biomarkers of the efficacy of LPMT. a. (English)
22 October 2020
0 references
Identifiers
CZ.01.1.02/0.0/0.0/16_079/0008825
0 references